Objective

Our mission at Notable Labs is to identify actionable treatment

protocols for cancer patients through a proprietary approach to

personalized drug repurposing. We screen a vast number of combinations

of FDA-approved drugs against a cancer patient’s cells to identify drug

combinations that have improved efficacy in vitro and can be

immediately prescribed by their doctor without a clinical trial. Our

current focus is screening for patients with glioblastoma multiforme

(GBM) and acute myeloid leukemia (AML). Technological advances allow

Notable Labs to intelligently screen more drugs and combinations on

fewer cells than before, and to interrogate larger datasets to glean

clinically relevant insights for each patient.